{"id":18128,"date":"2024-01-23T09:54:23","date_gmt":"2024-01-23T14:54:23","guid":{"rendered":"https:\/\/www.med.unc.edu\/neurology\/?p=18128"},"modified":"2025-02-28T12:21:52","modified_gmt":"2025-02-28T17:21:52","slug":"unc-neurology-joins-nih-strokenet-clinical-trials-network","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/neurology\/unc-neurology-joins-nih-strokenet-clinical-trials-network\/","title":{"rendered":"ºÚÁÏÍø Neurology Joins NIH StrokeNet Clinical Trials Network"},"content":{"rendered":"

This article was originally published by ºÚÁÏÍø on January 9,2024. ºÚÁÏÍø contact:<\/em> Mark Derewicz<\/a>, Director of Research News.<\/em><\/p>\n

\n

David Y. Hwang, MD, professor of neurology and division chief of neurocritical care, is co-principal investigator along with colleagues at Duke for a new eastern North Carolina and southern Virginia stroke clinical trial coordinating center.<\/em><\/p>\n

\n
\"David
David Hwang, MD, FAAN, FCCM, FNCS Professor of Neurology and Division Chief for Neurocritical Care Co-PI for the Duke\/ºÚÁÏÍø NINDS StrokeNet Regional Coordinating Center<\/figcaption><\/figure>\n

The National Institutes of Health has announced the creation of the Duke-ºÚÁÏÍø Eastern North Carolina and Southern Virginia Regional Stroke Trial Consortium \u2013 ENVISION \u2013 to bolster vascular neurology clinical trial participation and improve prevention, treatment, and recovery in adult and pediatric stroke populations. This regional coordinating center is one of the latest additions to\u00a0NIH StrokeNet<\/a>, a network of similar coordinating centers across the United States.<\/p>\n

Duke-ºÚÁÏÍø ENVISION, a five-year, $1.3-million project, consists of two major academic institutions serving as the network hubs \u2013 Duke and ºÚÁÏÍø-Chapel Hill \u2013 and nearly 30 regional hospitals with various stroke center designations, pediatric services, and rehabilitation facilities across eastern and central North Carolina, including the Triangle, as well as southeastern Virginia.<\/p>\n

This consortium is led by principal investigators\u00a0Wayne Feng, MD<\/a>, professor of neurology and division chief of stroke and vascular neurology,\u00a0Alexander Limkakeng, MD<\/a>, professor of emergency medicine, both at the Duke School of Medicine; and\u00a0David Y. Hwang, MD<\/a>, professor of neurology and division chief of neurocritical care at the ºÚÁÏÍø.<\/p>\n

\u201cWe will draw patients from a general population of nearly five million people, predominantly in suburban\/rural areas with a large proportion of under-represented groups,\u201d Hwang said. \u201cHistorically, this region is part of \u2018the Stroke Belt\u2019, with disproportionally higher stroke incidence and mortality. Together, we will pursue an organized strategy to enroll and retain a diverse population into stroke clinical trials with the ultimate goal of improving outcomes for patients and lessening the burden of stroke care for families across the region.\u201d<\/p>\n

There are three main aims of Duke-ºÚÁÏÍø ENVISION:<\/p>\n